What You Should Know:
- Glytec, a provider of an AI-powered technology platform for diabetes and related conditions, secures a $36M growth investment led by Savitr Capital and Hayfin Capital Management.
- The funding will fuel the continued expansion of Glytec’s platform, including its flagship Glucommander® SaaS solution, and accelerate the development of innovative new technologies. The investment comes as healthcare systems face increasing pressure to improve inpatient
Read More
Artera Launches Real-World Registry to Track AI’s Impact in Cancer Care
What You Should Know:
- Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the launch of its DIRECT-AI registry study. This new study will assess how the ArteraAI Prostate Test influences treatment decision-making between clinicians and patients with localized prostate cancer.
- The study will also monitor participants to evaluate their long-term cancer outcomes, reinforcing Artera's commitment to advancing
Read More
Omada Health Data Shows Companion Program Significantly Boosts GLP-1 Medication Persistence
What You Should Know:
- Omada Health, the virtual between-visit healthcare provider released new data demonstrating that its GLP-1 companion program significantly improves persistence rates for GLP-1 medications.
- The analysis found that members in Omada's program achieved weight loss results similar to those seen in controlled research settings, underscoring the importance of comprehensive support for individuals on these transformative medications.
- The findings provide
Read More
Walmart and Soda Health Launch “Everyday Health Signals™” Program for Medicare and Medicaid Members
What You Should Know:
- Walmart and Soda Health, a health technology company focused on smarter health benefits administration announced a collaboration to launch the Walmart Everyday Health Signals™ program.
- The strategic initiative will be available to select Medicare Advantage and Medicaid members, providing personalized nutrition and wellness guidance based on retail shopping insights.
- The program is designed to support day-to-day decisions for better health and
Read More
Erlanger Partners with Qventus to Drive Surgical Growth and Patient Access with AI
What You Should Know:
- Erlanger, a nationally-acclaimed, multi-hospital health system, today announced a strategic partnership with Qventus, the industry’s premier provider of AI-based care operations automation software. The collaboration is aimed at driving strategic surgical growth and increasing patient access to advanced, minimally invasive da Vinci procedures.
- The investment in Qventus’ Surgical Growth Solution is part of Erlanger’s commitment to leveraging the latest AI
Read More
Xsolis GenAI Pilot at Beacon Health System Reduces Medical Necessity Review Time by 68%
What You Should Know:
- Xsolis, an AI-driven technology company announced the initial results of its new generative AI (GenAI) solution pilot, which dramatically streamlines medical necessity reviews. Beacon Health System, a not-for-profit health system, piloted the new Xsolis GenAI solution and saw a significant decrease in administrative burden, which helped optimize precious clinical resources and streamline payer interactions.
- The results from the three-month pilot
Read More
Life After GLP-1s: New Report Shows How to Avoid Weight Regain
What You Should Know:
- A new report released by Virta Health, a leader in diabetes reversal and sustainable weight loss, offers an optimistic counter-narrative to the prevailing belief that weight regain is inevitable after stopping GLP-1 medications. The findings show that a structured, medically guided off-ramp combined with lifestyle support leads to sustained success, challenging the notion that these drugs must be a lifelong commitment.
- In partnership with Wakefield Research,
Read More
Medtronic Rebrands Diabetes Business as “MiniMed” Ahead of Spin-Off
What You Should Know:
- Medtronic announced that its planned New Diabetes Company will be named MiniMed. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001 and its deep, 40-year history of transforming diabetes care worldwide.
The announcement marks a significant step in the intended separation of Medtronic's Diabetes business into a new, independent entity.
Simplify Life with Diabetes
The new MiniMed's mission is to
Read More
Healthcare’s Digital Dilemma: AI Adoption Surges While Legacy Systems and Security Risks Lag Behind
What You Should Know:
- A new report from SOTI, "Healthcare’s Digital Dilemma: Calculated Risks and Hidden Challenges Exposed," reveals a growing divide in U.S. healthcare's digital transformation. While many organizations are rapidly embracing AI and mobile technologies to improve patient care, a significant number are being held back by outdated systems and rising security risks.
- The report, which surveyed 1,750 IT decision-makers across 11 countries, including 200 in the U.S.,
Read More
Eli Raises $12M to Launch the Hormometer™, The World’s First Real-Time Hormone Monitor
What You Should Know:
- Eli, a health technology company, announced it has raised $12M in Series A funding to scale its vision for real-time hormone monitoring led by BDC Capital’s Thrive Venture Fund, with participation from Muse Capital, TELUS Global Ventures, and other key investors. This brings the company's total funding to $20M.
- The new capital will be used to bring the Hormometer™—the world’s first instant hormone monitoring system—to millions of people, addressing a
Read More
